Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2003

Chiarle R, Inghirami G, Palestro G. Role of CD30 in the maturation of thymocytes and in the pathogenesis of autoimmune diseases. Pathologica. 2003;95(5):229-30.

Harigopal M, Hoda SA, Seshan SV. Images in pathology: congo-red negative fibrillary glomerulonephritis. Int J Surg Pathol. 2003;11(4):313.

Brenner RM, Slayden OD, Rodgers WH, Critchley HO, Carroll R, Nie XJ, et al. Immunocytochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometrium. Hum Reprod. 2003;18(6):1185-93.

Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2003:497-519.

Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, et al. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res. 2003;1(10):707-15.

Magro CM, Ross P, Kelsey M, W Waldman J, Pope-Harman A. Association of humoral immunity and bronchiolitis obliterans syndrome. Am J Transplant. 2003;3(9):1155-66.

Nucci MR, Castrillon DH, Bai H, Quade BJ, Ince TA, Genest DR, et al. Biomarkers in diagnostic obstetric and gynecologic pathology: a review. Adv Anat Pathol. 2003;10(2):55-68.

Murray SA, Zheng H, Gu L, Xiao Z-. IGF-1 activates p21 to inhibit UV-induced cell death. Oncogene. 2003;22(11):1703-11.

2002

Winter WE, Kucera PR, Rodgers W, McBroom JW, Olsen C, G Maxwell L. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol. 2002;100(4):671-6.

Sellers WR, Loda M. The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? Cancer Cell. 2002;2(5):349-50.